Literature DB >> 23893689

Proposal for the use in emergency departments of cardiac troponins measured with the latest generation methods in patients with suspected acute coronary syndrome without persistent ST-segment elevation.

Ivo Casagranda, Mario Cavazza, Aldo Clerico, Marcello Galvani, Filippo Ottani, Martina Zaninotto, Luigi Maria Biasucci, Gianfranco Cervellin, Tiziano Lenzi, Giuseppe Lippi, Mario Plebani, Marco Tubaro.   

Abstract

UNLABELLED: The purpose of this document is to develop recommendations on the use of the latest generation of cardiac troponins in emergency room settings for the diagnosis of myocardial infarction in patients with suspected acute coronary syndrome (ACS) without persistent ST-segment elevation (NSTE-ACS). The main points which have been addressed reaching a consensus are represented by: Suitability and appropriateness of the terminology. Appropriateness of the request. Confirmation of the diagnosis of myocardial infarction (rule-in). Exclusion of the diagnosis of myocardial infarction (rule-out). WORK
METHOD: Each point has been analyzed by taking into account the evidence presented in medical publications. Recommendations were developed using the criteria adopted by the European Society of Cardiology and the American Heart Association/American College of Cardiology (www.escardio.org/guidelines). Each point of the recommendation was submitted for validation to an external audit by a Group of Experts (named above).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23893689     DOI: 10.1515/cclm-2013-0423

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  9 in total

1.  Do clinicians decide relying primarily on Bayesian principles or on Gestalt perception? Authors' reply.

Authors:  Gianfranco Cervellin; Loris Borghi; Giuseppe Lippi
Journal:  Intern Emerg Med       Date:  2015-01-15       Impact factor: 3.397

2.  Cardiac biomarkers of acute coronary syndrome: from history to high-sensitive cardiac troponin.

Authors:  Mario Plebani; Giorgia Antonelli; Martina Zaninotto
Journal:  Intern Emerg Med       Date:  2017-02-17       Impact factor: 3.397

3.  Predictive significance of detectable cardiac troponin I measured with a contemporary-sensitive assay in a real life experience.

Authors:  Laura Bonfanti; Giuseppe Lippi; Irene Ciullo; Tiziana Meschi; Andrea Ticinesi; Rosalia Aloe; Francesco Di Spigno; Gianfranco Cervellin
Journal:  Ann Transl Med       Date:  2016-07

Review 4.  Diagnostic algorithms for acute coronary syndrome-is one better than another?

Authors:  Gianfranco Cervellin; Camilla Mattiuzzi; Chiara Bovo; Giuseppe Lippi
Journal:  Ann Transl Med       Date:  2016-05

Review 5.  High-sensitivity cardiac troponin testing in routine practice: economic and organizational advantages.

Authors:  Claudio Galli; Giuseppe Lippi
Journal:  Ann Transl Med       Date:  2016-07

Review 6.  Prognostic biomarkers in acute coronary syndrome.

Authors:  Gian Luca Salvagno; Chiara Pavan
Journal:  Ann Transl Med       Date:  2016-07

7.  High-density lipoprotein cholesterol values independently and inversely predict cardiac troponin T and I concentration.

Authors:  Giuseppe Lippi; Claudia Lo Cascio; Giorgio Brocco; Elisa Danese; Martina Montagnana; Antonella Bassi; Beatrice Caruso; Chiara Bovo; Gian Luca Salvagno
Journal:  Ann Transl Med       Date:  2016-05

8.  ANMCO-SIMEU Consensus Document: in-hospital management of patients presenting with chest pain.

Authors:  Guerrino Zuin; Vito Maurizio Parato; Paolo Groff; Michele Massimo Gulizia; Andrea Di Lenarda; Matteo Cassin; Gian Alfonso Cibinel; Maurizio Del Pinto; Giuseppe Di Tano; Federico Nardi; Roberta Rossini; Maria Pia Ruggieri; Enrico Ruggiero; Fortunato Scotto di Uccio; Serafina Valente
Journal:  Eur Heart J Suppl       Date:  2017-05-02       Impact factor: 1.803

9.  A Rational Adoption of the High Sensitive Assay for Cardiac Troponin I in Diagnostic Routine.

Authors:  Antonio Croce; Pietro Brunati; Carlo Colzani; Riccardo Terramocci; Stefano Favero; Gabriele Bordoni; Claudio Galli
Journal:  Dis Markers       Date:  2017-05-15       Impact factor: 3.434

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.